7th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 19-21, 2026 | Boston, Massachusetts, USA
Major Depressive Disorder and Treatment Innovations
With increasing rates of depression worldwide, clinicians are rethinking traditional treatment frameworks by integrating major depressive disorder and treatment innovations into routine psychiatric care. New approaches such as esketamine nasal spray, deep brain stimulation, and digital therapeutics are reshaping how depression is addressed, particularly in treatment-resistant populations. Psychotherapies like cognitive control training and acceptance-based strategies are also showing promising results. Combining neurobiological insights with technology, clinicians can now predict treatment response with greater accuracy, minimizing trial-and-error prescribing. This precision model supports faster recovery and fewer relapses. Emphasizing patient-centered care, new innovations allow for better symptom tracking, greater adherence, and reduced long-term impact on daily functioning.
John Michael Weber
Open Door Mission in Houston Texas, United States
Frederick J Goldstein
Philadelphia College of Osteopathic Medicine, United States
Nile Stanley
University of North Florida, United States
Andrew Drasen
A Vision of Hope Media, United States
Eric Cohen
Livio Labs, United States
John Michael Weber
Open Door Mission in Houston Texas, United States
Denis Larrivee
University of Navarra, SpainSubmit your abstract Today
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Reduction of chronic neuropathic pain by a THC-CBD combination capsule: ongoing pilot study
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Suicide prevention strategies for the law enforcement profession
Stephanie Schweitzer Dixon, SSD Consulting, United States
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College, United States
Title : The three-second neuroshift™: Reset before relapse for addiction & emotional dysregulation
Edie Raether, NeuroShifts and Wings for Wishes Academy, United States
Title : TAMAR (Trauma, Addiction, Mental Health, and Recovery)
Angelo Reynolds, Transformers Academy, LLC, United States